| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.73 | 0.007 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.51 | 0.06 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.25 | 1e-13 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.24 | 9e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.23 | 7e-10 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-10 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.23 | 8e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0001 |